Current status of clinical particle radiotherapy at Lawrence Berkeley laboratory

54Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Clinical experience with charged particle irradiation of human cancers has been underway at the University of California Lawrence Berkeley Laboratory. Over 150 patients have been irradiated with heavy charged particle beams including helium, carbon, neon, and argon ions. Pilot studies have included such tumor sites as glioma of the brain, carcinoma of the esophagus, carcinoma of the pancreas, carcinoma of the stomach, ocular melanoma, and carcinoma of the uterine cervix. Prospective studies are planned to investigate the improved dose localization potential (helium) and the enhanced biologic and physical dose potential (carbon, neon) in a controlled trial against the best available megavoltage irradiation techniques. Copyright © 1980 American Cancer Society

Cite

CITATION STYLE

APA

Castro, J. R., Quivey, J. M., Lyman, J. T., Chen, G. T. Y., Phillips, T. L., Tobias, C. A., & Alpen, E. L. (1980). Current status of clinical particle radiotherapy at Lawrence Berkeley laboratory. Cancer, 46(4), 633–641. https://doi.org/10.1002/1097-0142(19800815)46:4<633::AID-CNCR2820460402>3.0.CO;2-O

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free